Last $36.25 USD
Change Today -0.18 / -0.49%
Volume 1.2M
SGEN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for seattle genetics inc (SGEN)

Year over year, Seattle Genetics Inc. has seen their bottom line shrink from a loss of $62.5M USD to an even larger loss of $76.1M USD despite an increase in revenues from $269.3M USD to $286.8M USD. An increase in the percentage of sales devoted to SGA costs from 34.30% to 36.38% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
Press
Release
4 Year
Trend
Revenues94.8210.8269.3286.8
TOTAL REVENUES94.8210.8269.3286.8
Cost of Goods Sold166.5183.8239.8259.8
GROSS PROFIT-71.727.029.527.0
Selling General & Admin Expenses, Total72.784.392.4104.3
OTHER OPERATING EXPENSES, TOTAL72.784.392.4104.3
OPERATING INCOME-144.4-57.3-62.9-77.4
Interest and Investment Income1.13.50.31.2
NET INTEREST EXPENSE1.13.50.31.2
EBT, EXCLUDING UNUSUAL ITEMS-143.3-53.8-62.5-76.1
Gain (Loss) on Sale of Investments-8.7------
EBT, INCLUDING UNUSUAL ITEMS-152.0-53.8-62.5-76.1
Earnings from Continuing Operations-152.0-53.8-62.5-76.1
NET INCOME-152.0-53.8-62.5-76.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-152.0-53.8-62.5-76.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-152.0-53.8-62.5-76.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $36.25 USD -0.18

SGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $8.13 USD -0.04
Genmab A/S kr493.00 DKK -5.80
Insys Therapeutics Inc $60.06 USD -0.65
MorphoSys AG €74.66 EUR +0.153
Pfizer Ltd/India 1,993 INR 0.00
View Industry Companies
 

Industry Analysis

SGEN

Industry Average

Valuation SGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.7x
Price/Book 21.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.